The survival curve based on 124 patients with low/medium expression and 41 patients with high expression indicated that the expression level of CDKN1B mRNA had no significant effect on OS in rectal cancer (p > 0.05) (Supplementary Figure S7C). This evidence concerns the gene CDKN1B and rectal cancer.